ExpreS2ion will be participating in BioEquity Europe 2025, a leading investor conference for the European biopharma sector, taking place in Bruges on May 13-14, 2025.

CEO Bent Frandsen will present ExpreS2ion’s innovative pipeline and growth strategy in the Vaccine Platforms track on May 13th at 16:00, engaging with prominent European investors and pharmaceutical companies.

Join us to learn more about ExpreS2ion’s advancements and strategic initiatives.

For further event details, visit BioEquity Europe.